Inactivation of the Ecs ABC transporter of Staphylococcus aureus attenuates virulence by altering composition and function of bacterial wall

PLoS ONE

Volumn 5, Issue 12, 2010, Pages

  Jonsson, Ing Marie ^b   Juuti, Jarmo T ^a   François, Patrice ^c   AlMajidi, Rana ^a   Pietiäinen, Milla ^a   Girard, Myriam ^c   Lindholm, Catharina ^b   Saller, Manfred J ^d   Driessen, Arnold J M ^d   Kuusela, Pentti ^e,f   Bokarewa, Maria ^b   Schrenzel, Jacques ^c   Kontinen, Vesa P ^a,e  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^d UNIVERSITY OF GRONINGEN   (Netherlands)

^e UNIVERSITY OF HELSINKI   (Finland)

^f HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; ABC TRANSPORTER ECS; ADHESIN; ALPHA DEFENSIN; ANTIBIOTIC AGENT; BACTERIAL POLYSACCHARIDE; CHELERYTHRINE; LYSOSTAPHIN; PROTEIN A; SANGUINARINE; STAPHYLOKINASE; UNCLASSIFIED DRUG; BENZOPHENANTHRIDINE DERIVATIVE; ISOQUINOLINE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; AUTOLYSIS; BACTERIAL ARTHRITIS; BACTERIAL CELL WALL; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIAL VIRULENCE; CONTROLLED STUDY; DNA MICROARRAY; FEMALE; GENE EXPRESSION; MICROBIAL ACTIVITY; MOUSE; NONHUMAN; OPERON; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN TARGETING; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; WEIGHT REDUCTION; WILD TYPE; ANIMAL; CELL WALL; INTRON; METABOLISM; MUTATION; PATHOGENICITY; RIBOSOME; TRANSPORT AT THE CELLULAR LEVEL; VIRULENCE;

BACILLUS SUBTILIS; BACTERIA (MICROORGANISMS); FIRMICUTES; MUS; POSIBACTERIA; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS;

ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; AUTOLYSIS; BENZOPHENANTHRIDINES; BIOLOGICAL TRANSPORT; CELL WALL; FEMALE; INTRONS; ISOQUINOLINES; LYSOSTAPHIN; MICE; MUTATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHENOTYPE; RIBOSOMES; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; VIRULENCE;

EID: 78649956056     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0014209     Document Type: Article

References (40)

1. Ohlsen K, Dandekar G, Schwarz R, Dandekar T (2008) New trends in pharmacogenomic strategies against resistance development in microbial infections. Pharmacogenomics 9: 1711-1723.
2. Davidson AL, Dassa E, Orelle C, Chen J (2008) Structure, function, and evolution of bacterial ATP-binding cassette systems. Microbiol Mol Biol Rev 72: 317-364.
3. Braun V, Pramanik A, Gwinner T, Koberle M, Bohn E (2009) Sideromycins: tools and antibiotics. Biometals 22: 3-13.
4. Henderson DP, Payne SM (1994) Vibrio cholerae iron transport systems: roles of heme and siderophore iron transport in virulence and identification of a gene associated with multiple iron transport systems. Infect Immun 62: 5120-5125.
5. Koster W (2001) ABC transporter-mediated uptake of iron, siderophores, heme and vitamin B12. Res Microbiol 152: 291-301.
6. Kontinen VP, Sarvas M (1988) Mutants of Bacillus subtilis defective in protein export. J Gen Microbiol 134: 2333-2344.
7. Leskelä S, Kontinen VP, Sarvas M (1996) Molecular analysis of an operon in Bacillus subtilis encoding a novel ABC transporter with a role in exoprotein production, sporulation and competence. Microbiology 142: 71-77.
8. Leskelä S, Wahlström E, Hyyryläinen HL, Jacobs M, Palva A, et al. (1999) Ecs, an ABC transporter of Bacillus subtilis: dual signal transduction functions affecting expression of secreted proteins as well as their secretion. Mol Microbiol 31: 533-543.
9. Pummi T, Leskelä S, Wahlström E, Gerth U, Tjalsma H, et al. (2002) ClpXP protease regulates the signal peptide cleavage of secretory preproteins in Bacillus subtilis with a mechanism distinct from that of the Ecs ABC transporter. J Bacteriol 184: 1010-1018.
10. Branda SS, Gonzalez-Pastor JE, Dervyn E, Ehrlich SD, Losick R, et al. (2004) Genes involved in formation of structured multicellular communities by Bacillus subtilis. J Bacteriol 186: 3970-3979.
11. Heinrich J, Lunden T, Kontinen VP, Wiegert T (2008) The Bacillus subtilis ABC transporter EcsAB influences intramembrane proteolysis through RasP. Microbiology 154: 1989-1997.
12. Chambers HF, Deleo FR (2009) Waves of resistance: Staphylococcus aureus in the antibiotic era. Nat Rev Microbiol 7: 629-641.
13. Falcone M, Serra P, Venditti M (2009) Serious infections due to methicillinresistant Staphylococcus aureus: an evolving challenge for physicians. Eur J Intern Med 20: 343-347.
14. Bremell T, Lange S, Yacoub A, Ryden C, Tarkowski A (1991) Experimental Staphylococcus aureus arthritis in mice. Infect Immun 59: 2615-2623.
15. Baba T, Bae T, Schneewind O, Takeuchi F, Hiramatsu K (2008) Genome sequence of Staphylococcus aureus strain Newman and comparative analysis of staphylococcal genomes: polymorphism and evolution of two major pathogenicity islands. J Bacteriol 190: 300-310.
16. Forsyth RA, Haselbeck RJ, Ohlsen KL, Yamamoto RT, Xu H, et al. (2002) A genome-wide strategy for the identification of essential genes in Staphylococcus aureus. Mol Microbiol 43: 1387-1400.
17. Pishchany G, Dickey SE, Skaar EP (2009) Subcellular localization of the Staphylococcus aureus heme iron transport components IsdA and IsdB. Infect Immun 77: 2624-2634.
18. Miller M, Donat S, Rakette S, Stehle T, Kouwen TR, et al. Staphylococcal PknB as the first prokaryotic representative of the proline-directed kinases. PLoS One 5: e9057.
19. Corrigan RM, Miajlovic H, Foster TJ (2009) Surface proteins that promote adherence of Staphylococcus aureus to human desquamated nasal epithelial cells. BMC Microbiol 9: 22. doi: 10.1186/1471-2180-1189-1122.
20. Jelsbak L, Hemmingsen L, Donat S, Ohlsen K, Boye K, et al. (2009) Growth phase-dependent regulation of the global virulence regulator Rot in clinical isolates of Staphylococcus aureus. Int J Med Microbiol;doi:10.1016/ j.ijmm.2009.1007.1003.
21. Palmqvist N, Foster T, Tarkowski A, Josefsson E (2002) Protein A is a virulence factor in Staphylococcus aureus arthritis and septic death. Microb Pathog 33: 239-249.
22. Patel AH, Nowlan P, Weavers ED, Foster T (1987) Virulence of protein Adeficient and alpha-toxin-deficient mutants of Staphylococcus aureus isolated by allele replacement. Infect Immun 55: 3103-3110.
23. Jung KY, Cha JD, Lee SH, Woo WH, Lim DS, et al. (2001) Involvement of staphylococcal protein A and cytoskeletal actin in Staphylococcus aureus invasion of cultured human oral epithelial cells. J Med Microbiol 50: 35-41.
24. Merino N, Toledo-Arana A, Vergara-Irigaray M, Valle J, Solano C, et al. (2009) Protein A-mediated multicellular behavior in Staphylococcus aureus. J Bacteriol 191: 832-843.
25. Gao J, Stewart GC (2004) Regulatory elements of the Staphylococcus aureus protein A (Spa) promoter. J Bacteriol 186: 3738-3748.
26. Gustafsson E, Karlsson S, Oscarsson J, Sogard P, Nilsson P, et al. (2009) Mathematical modelling of the regulation of spa (protein A) transcription in Staphylococcus aureus. Int J Med Microbiol 299: 65-74.
27. Bramkamp M, Weston L, Daniel RA, Errington J (2006) Regulated intramembrane proteolysis of FtsL protein and the control of cell division in Bacillus subtilis. Mol Microbiol 62: 580-591.
28. Schobel S, Zellmeier S, Schumann W, Wiegert T (2004) The Bacillus subtilis sigmaW anti-sigma factor RsiW is degraded by intramembrane proteolysis through YluC. Mol Microbiol 52: 1091-1105.
29. Ganz T (1999) Defensins and host defense. Science 286: 420-421.
30. Lehrer RI, Barton A, Daher KA, Harwig SS, Ganz T, et al. (1989) Interaction of human defensins with Escherichia coli. Mechanism of bactericidal activity. J Clin Invest 84: 553-561.
31. Wimley WC, Selsted ME, White SH (1994) Interactions between human defensins and lipid bilayers: evidence for formation of multimeric pores. Protein Sci 3: 1362-1373.
32. Schiott T, Throne-Holst M, Hederstedt L (1997) Bacillus subtilis CcdA-defective mutants are blocked in a late step of cytochrome c biogenesis. J Bacteriol 179: 4523-4529.
33. Bae T, Schneewind O (2005) Allelic replacement in Staphylococcus aureus with inducible counter-selection. Plasmid 55: 58-63.
34. Pietiäinen M, Francois P, Hyyryläinen HL, Tangomo M, Sass V, et al. (2009) Transcriptome analysis of the responses of Staphylococcus aureus to antimicrobial peptides and characterization of the roles of vraDE and vraSR in antimicrobial resistance. BMC Genomics 10: 429. doi: 410.1186/1471-2164-1110-1429.
35. de Jonge BL, de Lencastre H, Tomasz A (1991) Suppression of autolysis and cell wall turnover in heterogeneous Tn551 mutants of a methicillin-resistant Staphylococcus aureus strain. J Bacteriol 173: 1105-1110.
36. Grundling A, Missiakas DM, Schneewind O (2006) Staphylococcus aureus mutants with increased lysostaphin resistance. J Bacteriol 188: 6286-6297.
37. Helle M, Boeije L, Aarden LA (1988) Functional discrimination between interleukin 6 and interleukin 1. Eur J Immunol 18: 1535-1540.
38. von Eiff C, McNamara P, Becker K, Bates D, Lei XH, et al. (2006) Phenotype microarray profiling of Staphylococcus aureus menD and hemB mutants with the small-colony-variant phenotype. Journal of Bacteriology 188: 687-693.
39. Pohl K, Francois P, Stenz L, Schlink F, Geiger T, et al. (2009) CodY in Staphylococcus aureus: a regulatory link between metabolism and virulence gene expression. J Bacteriol 191: 2953-2963.
40. Churchill GA (2004) Using ANOVA to analyze microarray data. Biotechniques 37: 173-175.